Stockscreener 앱 받기
7.68
10.39%
-0.89
시간 외 거래:
7.67
-0.010
-0.13%
전일 마감가:
$8.57
열려 있는:
$8.6
하루 거래량:
140.63K
Relative Volume:
2.06
시가총액:
$205.50M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-13.51%
1개월 성능:
-29.93%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$7.30
$8.725
1주일 범위
$7.30
$10.19
52주 변동 폭
$7.30
$18.79
Conexeu Sciences Inc Stock (CNXU) Company Profile
명칭
Conexeu Sciences Inc
전화
604-315-4722
주소
50 WEST LIBERTY STREET, SUITE 880, RENO
Compare CNXU vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNXU
Conexeu Sciences Inc
|
7.68 | 229.32M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Conexeu Sciences Inc 주식(CNXU)의 최신 뉴스
Top Conexeu Sciences (CNXU) Competitors 2026 - MarketBeat
Short Interest in Conexeu Sciences Inc. (NASDAQ:CNXU) Expands By 357.1% - MarketBeat
CNXU|Conexeu Sciences Ord Shs|Price:8.570|Chg%:-0.580 - TradingKey
Conexeu Sciences Ord Shs (CNXU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Conexeu Sciences Inc. Revenue Breakdown – NASDAQ:CNXU - TradingView
Paisley Capital reports 1.8M-share position in Conexeu Sciences Inc. (CNXU) - Stock Titan
David Robert Bogart Net Worth (2026) - GuruFocus
Conexeu Sciences (CNXU) 10K Form and Latest SEC Filings 2026 - MarketBeat
Ana Lucia Bastiani Posner Net Worth (2026) - GuruFocus
Aaron Solomon Farberg Net Worth (2026) - GuruFocus
Jeffrey Nathan Sharpe Net Worth (2026) - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
Conexeu Sciences Inc.Common Stock (CNXU) Stock Price, News, Quote & History - FinancialContent
Breakeven Is Near for Pulsar Group plc (LON:PULS) - simplywall.st
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
GLP-1 Aesthetic Care Projected to Reach $2B by 2030 - Stock Titan
CNXU Price Today: Conexeu Sciences Inc. Stock Price, Quote & Chart | MEXC - mexc.co
The GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It. - PR Newswire
A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next - marketscreener.com
Bullish NeOnc Technologies Holdings Insider Buying Worth US$615.6k Yet To Pay Off - simplywall.st
Conexeu Sciences Launches CXU™ Platform for Injectable Aesthetics - Intellectia AI
Stocks & Markets Podcast: Regenerative Medicine’s Next Leap with Conexeu Sciences CEO - TheStreet Pro
Conexeu targets $2B injectable aesthetics marke... - Pluang
Conexeu Sciences Details Completion Of 12-Month P.R.O.O.F. Preclinical Study For CXU Platform - marketscreener.com
The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It - The Manila Times
OneWater Marine Inc. (NASDAQ:ONEW): Is Breakeven Near? - simplywall.st
CNXU Stock Price and Chart — NASDAQ:CNXU - TradingView
Claudia Itze Chavez Munoz Net Worth (2026) - GuruFocus
Michael G. Wright Net Worth (2026) - GuruFocus
April Lynn Burke Net Worth (2026) - GuruFocus
Stephen Douglas Inouye Net Worth (2026) - GuruFocus
Conexeu Sciences (CNXU) Insider Trading Activity 2026 - MarketBeat
Flourish Adoption - AOL.com
CNXU Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Onepointtwo Capital Ventures Llc Net Worth (2026) - GuruFocus
Miles David Harrison Net Worth (2026) - GuruFocus
Onepointtwo Capital Ventures Ii Llc Net Worth (2026) - GuruFocus
Brian Keith Pilcher Net Worth (2026) - GuruFocus
One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics - Investing News Network
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Conexeu Sciences (CNXU) Targets Medical Aesthetics Market Amid G - GuruFocus
Conex Completes 12-Month P.R.O.O.F Preclinical Study, Targets Q1 2027 510(k) for Wound Care - TradingView
[8-K] Conexeu Sciences Inc. Reports Material Event - Stock Titan
Sanken Electric Co., Ltd. (6707) - MSN
A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill It - PR Newswire
A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill - The Manila Times
Enterprise value to EBITDA forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Conexeu Sciences (CNXU) Earnings Date and Reports 2026 - MarketBeat
CNXU Should I Buy - Intellectia AI
Conexeu Sciences Inc. Common Stock (NASDAQ: CNXU) Stock Price, News & Analysis - Kalkine
Price to book forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Conexeu Sciences Inc (CNXU) 재무 분석
Conexeu Sciences Inc (CNXU)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.97%
0.83%
자본화:
|
볼륨(24시간):